Yes I agree sarge - Neuren's assets could be the making of Acadia, there's at least a decade's worth of work just in Trofinetide and other possible indications. We know they have Fragile X in their pocket and likely up next. There's more to it than just those two in my view.
So it is good that NNZ-2591 has some indication targets already made public. The non-compete clause is, in my interpretation, to prevent NNZ-2591 being applied to Rett's and FX. Which is fine, we have bigger fish to fry with NNZ2591 anyway.
Where to in 2021?, page-20
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.05 |
Change
-0.510(3.50%) |
Mkt cap ! $1.795B | |||
| Open | High | Low | Value | Volume |
| $14.38 | $14.42 | $13.94 | $6.419M | 454.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $13.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.07 | 6644 | 4 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |